miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells

Nintedanib (BIBF1120) is a multi-targeted angiokinase inhibitor and has been evaluated in idiopathic pulmonary fibrosis and advanced non-small cell lung cancer (NSCLC) patients in clinical studies. In the present study, we evaluated the antitumor effects of nintedanib in 16 NSCLC cell lines and trie...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Oncol
Hlavní autoři: NISHIJIMA, NOBUHIKO, SEIKE, MASAHIRO, SOENO, CHIE, CHIBA, MIKA, MIYANAGA, AKIHIKO, NORO, RINTARO, SUGANO, TEPPEI, MATSUMOTO, MASARU, KUBOTA, KAORU, GEMMA, AKIHIKO
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2016
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4750530/
https://ncbi.nlm.nih.gov/pubmed/26783187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2016.3331
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky